How to Evaluate Joint Health Supplements: What Clinicians Should Look for in the Research

Active adults want to keep moving, and someone in their fifties who hikes, cycles, or plays tennis twice a week wants to know whether a daily capsule is worth taking. A label claim can guide individuals, but it isn’t evidence. For clinicians, the research behind a joint supplement is valuable information used to make a recommendation.

The category is crowded, and the evidence behind individual products varies widely, so knowing how to read that research comes first.

What the Evidence Says About Legacy Ingredients

Glucosamine and chondroitin have anchored joint supplementation for decades, and roughly 6.5 million Americans take glucosamine annually. Both are naturally present in the cartilage matrix, and supplementation has a plausible mechanistic rationale, since the ingredients supply raw material the tissue uses.

Trials haven’t consistently shown that supplying that raw material changes outcomes. Multiple meta-analyses, including reviews published in JAMA, Inflammopharmacology, and Archives of Orthopaedic and Trauma Surgery, have found small or inconsistent effects compared to placebo, with significant variability across product quality and formulation. Current evidence does not support that either ingredient achieves cartilage regeneration. This leaves practitioners evaluating whether the research behind newer options is more rigorous.

What Clinicians Should Look for in a Joint Health Supplement

These five criteria tell clinicians what was studied, enabling them to make more informed choices about supplements.

Finished-formulation research. Many claims extrapolate from ingredient-level studies conducted on materials that bear little resemblance to the capsule an individual actually takes. Research on the complete, finished product maps directly to what gets recommended.

Study design progression. A layered evidence base carries more weight than a single study. Large-scale prospective or observational data followed by a controlled design allows a signal to be tested rather than assumed.

Validated outcome measures. The WOMAC pain scale and six-minute walk test are standardized instruments that allow comparison across populations and studies.

Objective endpoints alongside participant-reported ones. Most joint supplement trials rely entirely on participant self-report. Biomarker data adds a second, independent layer of evidence.

Manufacturing standards. cGMP compliance and batch testing for identity, purity, and potency are baseline requirements. Their absence can raise questions about quality.

Applying the Framework: A Worked Example

Cartigenix HP® with RestorCel™, from Calroy Health Sciences, has been evaluated in three published human studies covering more than 1,700 participants across multiple study designs, and it meets each criterion above.*† 

The three studies progress from scale to control. Desai 2022, a prospective study of 1,236 adults aged 19 to 75 over 90 days, reported a 72.5% improvement in WOMAC pain scores.*† Desai 2024, an observational study of 394 adults aged 18 and over, reported a 75% improvement in WOMAC pain scores and a 79% improvement in function scores.*† Vaidya 2025, a randomized, double-blind, placebo-controlled trial, evaluated the formulation over 90 days and reported a 64% improvement in WOMAC pain scores and a 50% improvement in walking distance.*† Each study evaluated the finished formulation rather than isolated ingredients, providing formulation-specific outcomes.

“I recommended glucosamine and chondroitin to patients for years. It was the standard of care, and there wasn’t much else to point to,” Tom Bayne, DC, educator with Calroy Health Sciences, said. “The honest answer when patients asked if it would work was ‘maybe.’ What’s different now is that we have published research, including a placebo-controlled study, with measurable outcomes on a new supplement. That gives clinicians and patients confidence.”

Comparing Products on the Same Terms

The five criteria don’t identify a single answer. They give clinicians a consistent basis for comparison, so products are assessed on the same terms rather than on the strength of their marketing. With that basis in place, a clinician can provide a recommendation and explain the reasoning behind it.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

†As shown in a placebo-controlled, randomized, controlled human research study (Vaidya 2025) and an observational study (Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).

FAQs

Question: What are glucosamine and chondroitin?
Answer: Glucosamine is an amino sugar found in cartilage and synovial fluid. Chondroitin is a compound present in cartilage and other connective tissues that helps retain water. Both are naturally occurring in the body and are commonly combined in joint supplements intended to support cartilage structure and mobility.

Question: What is the WOMAC pain scale?
Answer: WOMAC, or the Western Ontario and McMaster Universities index, is a validated instrument that captures self-reported joint discomfort, stiffness, and function across standardized domains. Its standardization allows outcomes to be compared across different populations, which is why it appears frequently as a joint health outcome measure.

Question: What is the six-minute walk test?
Answer: A functional assessment measuring the distance a person can walk in six minutes. It translates joint comfort into a mobility outcome, reflecting what someone can actually do rather than how they describe feeling. It is widely used as a standardized measure of practical, real-world movement capacity.

Question: What are cartilage biomarkers?
Answer: Objective biological measures that detect activity at the tissue level of cartilage. PIIANP and PIICP are markers of type II procollagen, the building block of cartilage matrix. They are research tools rather than lab tests a healthcare provider would order in routine practice.

M&F and editorial staff were not involved in the creation of this content.